Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [18F]FBPA in human and mouse tumour cell lines.
暂无分享,去创建一个
C. Kuntner | O. Langer | T. Wanek | J. Stanek | Viktoria E Muchitsch | S. Mairinger | B. Wingelhofer | Katharina Kreis
[1] C. Kuntner,et al. Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG. , 2015, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[2] I. Kato,et al. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2 , 2015, Cancer science.
[3] T. Watabe,et al. FBPA PET in boron neutron capture therapy for cancer: prediction of 10B concentration in the tumor and normal tissue in a rat xenograft model , 2014, EJNMMI Research.
[4] G. Kabalka,et al. Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models. , 2014, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[5] J. Itami,et al. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells. , 2013, Nuclear medicine and biology.
[6] G. Jori,et al. Boron neutron capture therapy and 18F-labelled borophenylalanine positron emission tomography: a critical and clinical overview of the literature. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[7] A. Paetau,et al. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study. , 2011, International journal of radiation oncology, biology, physics.
[8] T. Gorlia,et al. Boron neutron capture therapy for newly diagnosed glioblastoma multiforme: an assessment of clinical potential. , 2010, The British journal of radiology.
[9] G. Mazzini,et al. Extra-corporeal liver BNCT for the treatment of diffuse metastases: what was learned and what is still to be learned. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[10] K. Ishii,et al. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[11] H. Minn,et al. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[12] C. Cametti,et al. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[13] M. Yliperttula,et al. Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[14] C. Cametti,et al. L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. , 2008, International journal of radiation oncology, biology, physics.
[15] L. Collette,et al. Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001) , 2007, International journal of cancer.
[16] L. Salford,et al. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] G. Mazzini,et al. Clinical lessons from the first applications of BNCT on unresectable liver metastases. , 2006 .
[18] M. Vicente,et al. Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.
[19] M. Palacín,et al. Identification of LAT4, a Novel Amino Acid Transporter with System L Activity* , 2005, Journal of Biological Chemistry.
[20] Emilija Veljkovic,et al. SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Jeng-Jong Hwang,et al. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] E. Babu,et al. Identification of a Novel System L Amino Acid Transporter Structurally Distinct from Heterodimeric Amino Acid Transporters* , 2003, Journal of Biological Chemistry.
[23] T. L. Nichols,et al. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography. , 2002, Medical physics.
[24] Y. Kanai,et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. , 2001, Biochimica et biophysica acta.
[25] A. Wittig,et al. Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro , 2000, Radiation research.
[26] K. Ono,et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] L. Feinendegen,et al. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells. , 1994, Cancer research.
[28] Hiroshi Fukuda,et al. TREATMENT OF MALIGNANT MELANOMA BY SINGLE THERMAL NEUTRON CAPTURE THERAPY WITH MELANOMA-SEEKING 10B-COMPOUND , 1989, The Lancet.
[29] J. Coderre,et al. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. , 1987, Cancer research.
[30] M. Kilberg,et al. The regulation of neutral amino acid transport in mammalian cells. , 1983, Biochimica et biophysica acta.
[31] K. Ishiwata,et al. 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.